- Investing Ideas
- Canadian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Canadian Pharmaceuticals & Biotech Mid-Large Cap Stocks
Results
4
0 new
Mid-Large Cap Stocks
4 companies
Curaleaf Holdings
Market Cap: CA$3.5b
Engages in the retail and wholesale of cannabis products in the United States and internationally.
CURA
CA$13.29
7D
-3.1%
1Y
35.5%
Cronos Group
Market Cap: CA$1.6b
A cannabinoid company, engages in the cultivation, production, distribution, and marketing of cannabis products in Canada, Israel, and internationally.
CRON
CA$4.32
7D
-4.0%
1Y
23.4%
Green Thumb Industries
Market Cap: CA$2.2b
Manufactures, distributes, markets, and sells of cannabis products for medical and adult-use in the United States.
GTII
CA$9.91
7D
-7.5%
1Y
1.8%
Apotex Health
Market Cap: CA$8.1b
Operates as a pharmaceutical manufacturing company in Canada, the United States, Mexico, and India.
APTX
CA$35.55
7D
5.7%
1Y
n/a